Priorix Vaccine

• Active immunization against infection by measles, mumps and rubella
• Routine vaccination of children (12-15 months and 4-6 years)
• Vaccination of adults (19-49 years)
• Rubella immunization in non-pregnant women
• International travelers and healthcare workers

Pediatric Dose (IM/SC):

• 12-15 months: 0.5 mL SC (1st dose)
• 4-6 years: 0.5 mL SC (2nd dose)
• Minimum time between 1st and 2nd dose: 4 weeks

Adult Dose (IM/SC):

• 19-49 years: 0.5 mL SC; second dose may be given 28 days apart
• >50 years: 0.5 mL SC (1 dose only)

Immunization in Pregnancy: Give MMR vaccine after pregnancy completion; avoid pregnancy for 28 days after vaccination

Common Side Effects:

• Fever
• Headache
• Rash
• Pain at injection site
• Lymphadenopathy
• Myalgia
• Malaise, irritability

Rare: Ataxia, Thrombocytopenia, Optic neuritis, Encephalitis, Guillain-Barre syndrome, Seizures, Parotitis, Bronchospasm, Stevens-Johnson syndrome, Nerve deafness

Use in Pregnancy: Contraindicated in pregnancy. Avoid pregnancy for 28 days after vaccination. May be given after pregnancy completion.

• Caution in patients with history of cerebral injury or seizures
• Caution in patients with thrombocytopenia and those who develop thrombocytopenia after 1st dose
• Tuberculosis treatment should be started before vaccine use in active TB patients
• Vaccination may be deferred in moderate or severe acute illness
• Avoid pregnancy for 28 days after vaccination